Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review
Shilpa Gopinath, Angela Ishak, Naveen Dhawan, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 5, pp. 81-81
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

First COVID-19 Booster Dose in the General Population: A Systematic Review and Meta-Analysis of Willingness and Its Predictors
Petros Galanis, Irène Vraka, Aglaia Katsiroumpa, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1097-1097
Open Access | Times Cited: 45
Interplay Between Viral Shedding, Age, and Symptoms in Individual Infectivity of COVID-19 Breakthrough Infections in Households
Shuaibing Dong, Ying Sun, Shuyu Ni, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 329-329
Open Access
Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study
Filipa Ladeira, Cláudia Nóbrega, João Cerqueira
Journal of Neurology (2025) Vol. 272, Iss. 4
Open Access
Online learning during the COVID-19 pandemic: academic survival of international PhD students in the digital era
Andrea Lazaro, Sweetbert Mugizi Anselimus
Cogent Education (2025) Vol. 12, Iss. 1
Open Access
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination
Alexander Hönning, Sara Tomczyk, Júlia Hermes, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience
Angioletta Lasagna, Giuseppe Albi, Simone Figini, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1269-1269
Open Access | Times Cited: 8
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
Nicole Roth, Janina Gergen, Kristina Kovacikova, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 318-318
Open Access | Times Cited: 7
COVID-19 vaccines breakthrough infection and adverse reactions in medical students: a nationwide survey in Iran
Amirreza Allahgholipour, Seyed Amir Ahmad Safavi‐Naini, Zahra Shekarriz Foomany, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 2
Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination
Lukas Page, Kevin M. Dennehy, Katharina Mueller, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Real-world effectiveness of COVID-19 vaccines: A retrospective cohort study of vaccinated individuals in Jazan, Saudi Arabia
Mohammed Y. Elamin, Yahya Maslamani, Mohammed A. Muaddi, et al.
Journal of Infection and Public Health (2023) Vol. 16, Iss. 9, pp. 1512-1517
Open Access | Times Cited: 6
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment
Angioletta Lasagna, Irene Cassaniti, Daniele Lilleri, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 9
Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2
Asish Kumar Ghosh, Olfert Landt, Mahmuda Yeasmin, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1959-1959
Open Access | Times Cited: 9
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
Prasad S. Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago
Fabiola M Moreno Echevarria, Mathew Caputo, Daniel M. Camp, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0302338-e0302338
Open Access | Times Cited: 1
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal Study
Pere Torán‐Monserrat, Noemí Lamonja-Vicente, Anna Costa-Garrido, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e56926-e56926
Open Access | Times Cited: 1
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-based Omicron COVID-19 Vaccination in Small Animal Models
Nicole Roth, Janina Gergen, Kristina Kovacikova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
COVID-19: Current Status and Future Prospects
Peter A. Leggat, John Frean, Lucille Blumberg
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 2, pp. 94-94
Open Access | Times Cited: 1
COVID-19: Current Status and Future Prospects

MDPI eBooks (2023)
Open Access | Times Cited: 1
Effects of antivirals on patients with COVID-19 breakthrough
Hong Tham Pham, Tuong-Anh Mai-Phan, Kim-Huong Truong-Nguyen, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
Leonardo Santos Hoff, R Naveen, Parikshit Sen, et al.
Lara D. Veeken (2024)
Open Access
Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individuals.
Fabiola M Moreno Echevarria, Mathew T. Caputo, Daniel M. Camp, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Predictive Assessment of the Antiviral Properties of Imperata cylindrica against SARS‐CoV‐2
Frank Eric Tatsing Foka, Hazel Tumelo Mufhandu
Advances in Virology (2024) Vol. 2024, Iss. 1
Open Access
Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France
Alice Casenaz, Sandrine Grosjean, Serge Aho, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 2
Funding Public Health Action Programs: Allocations, Budget Execution and Post-Audit Results at the Level of the First Pandemic Year
Patricia Bostan, Nicoleta Asaloș, Ionel Bostan
Ovidius University Annals Economic Sciences Series (2022) Vol. 22, Iss. 1, pp. 793-802
Open Access | Times Cited: 2
Perspectives on the Development of Public Health System’s Infrastructure in the Context of PNRR’s Implementation
Patricia Bostan, Cristina Lazăr, Ionel Bostan
Ovidius University Annals Economic Sciences Series (2023) Vol. 22, Iss. 1, pp. 22-31
Open Access
Page 1 - Next Page

Scroll to top